Dow Up1.40% Nasdaq Up1.77%

Vanda Pharmaceuticals, Inc. (VNDA)

-NasdaqGM
11.06 Down 0.12(1.07%) 12:26PM EDT - Nasdaq Real Time Price
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingMar 31, 2016Dec 31, 2015Sep 30, 2015Jun 30, 2015
Total Revenue 33,262   31,849   28,344   27,582  
Cost of Revenue5,956  6,171  6,510  5,766  
Gross Profit 27,306   25,678   21,834   21,816  
Operating Expenses
Research Development7,548  8,747  9,974  5,946  
Selling General and Administrative29,290  28,881  18,458  18,386  
Non Recurring -   -   -   -  
Others2,943  2,943  2,943  2,942  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (12,475) (14,893) (9,541) (5,458)
Income from Continuing Operations
Total Other Income/Expenses Net117  95  81  72  
Earnings Before Interest And Taxes(12,358)(14,798)(9,460)(5,386)
Interest Expense -   -   -   -  
Income Before Tax(12,358)(14,798)(9,460)(5,386)
Income Tax Expense -   -   -   -  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(12,358)(14,798)(9,460)(5,386)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (12,358) (14,798) (9,460) (5,386)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (12,358) (14,798) (9,460) (5,386)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.